Pages tagged “advocacy”
-
ACS Guidance for Dispensaries in Providing Care to Patients
ACS Guidance for Dispensaries in Providing Care to Patients
The ACS believes that cannabis dispensaries play a vital role in providing care and products to patients. Ideally, dispensaries provide access to high-quality, regulated, and tested cannabis in appropriate forms and for use in appropriate routes of administration to meet patients’ medical needs.
Written by Jordan Tishler
February 24, 2024 -
ACS Expectations of CME Requirements for Cannabis Specialists
ACS Expectations of CME Requirements for Cannabis Specialists
Cannabis Specialists (MD, DO, NP, or PA if authorized by each state program) must keep up to date on the emerging data in the field. Their ability to provide medically appropriate, helpful, and safe treatment depends on being aware of new data in a field that, unlike many more established fields of medicine, is changing weekly if not more frequently.
Written by Jordan Tishler
February 20, 2024 -
A Federal Framework of Regulation for Medical Cannabis Use
A Federal Framework of Regulation for Medical Cannabis Use
While a patchwork of state cannabis laws exists, the lack of a unified, federal framework regulating medical cannabis places patients at risk, and undermines the relationships that doctors must maintain to ensure an effective and safe treatment paradigm. Such a framework is both overdue and sorely needed for safe, optimized care of patients across the country.
Written by Jordan Tishler
February 20, 2024 -
Navigating Cannabis Research: Deciphering 32,000 Articles
Navigating Cannabis Research: Deciphering 32,000 Articles
In recent years, the field of cannabis research has experienced an unprecedented boom, with a staggering 32,000 articles shedding light on various aspects of cannabinoid medicine.
Written by Jordan Tishler
February 13, 2024 -
ACS’s Guidance on Driving as a Medical Cannabis Patient
ACS’s Guidance on Driving as a Medical Cannabis Patient
Many medications, like benzodiazepines, opioids, and antibiotics can lead to impairment. We do not prospectively penalize patients who use these substances. We expect that patients monitor their own impairment and not drive when incapable.
Written by Jordan Tishler
February 08, 2024 -
Why Call It Cannabis Instead of Marijuana or Another Name?
Why Call It Cannabis Instead of Marijuana or Another Name?
Cannabis by any other name would work just the same. So why should we stick with calling it cannabis?
Written by Kelsey Engvik
October 09, 2023 -
The World Needs Big Ideas: An Association for Cannabis Clinicians
The World Needs Big Ideas: An Association for Cannabis Clinicians
In Part 1, “Who Needs a Professional Association for Cannabis Clinicians?”, I wrote about the importance of creating Association of Cannabinoid Specialists when I realized there was a big gap in patient care information for clinicians.
Written by Jordan Tishler
September 05, 2023 -
CBD RFI Response from Association of Cannabinoid Specialists
CBD RFI Response from Association of Cannabinoid Specialists
Recently ACS was asked to provide a response to the request for information from Congress with regard to regulation of CBD and derivatives. The full response is available below and in pdf form here.
Written by Jordan Tishler
August 22, 2023 -
Who Needs an Association for Cannabis Professionals? Part 1
Who Needs an Association for Cannabis Professionals? Part 1
I’m Jordan Tishler, the founder and president of the Association of Cannabinoid Specialists. This is the story of why I founded ACS and why the world needs a place for clinicians to learn more about cannabis medicine and influence cannabis policy.
Written by Jordan Tishler
August 15, 2023 -
Casual Conversations #2 Why A Cannabis Medical Specialist
Casual Conversations #2 Why A Cannabis Medical Specialist
The guests in this Episode of Casual Conversations emphasize the need for medical professionals in cannabis treatment, discussing the complexities of dosing and the individualized nature of cannabis therapy.
Written by Kelsey Engvik
July 15, 2023